Financials • Investment Managers
$139.34 ▲ +1.96
(+1.43%)
MKT CAP: $9.74B • VOL: 1.65M
52W L $113 52W H $195
HLI // SEC EDGAR XBRL STANDARDIZED FINANCIAL STATEMENTS (FA <GO>)
| LINE ITEM (USD / %) | FY 2025
FILED 2026-03-31 | FY 2024
FILED 2025-03-31 | FY 2023
FILED 2024-03-31 |
|---|---|---|---|
| Revenue (Total Sales) | $2.62B | $2.39B | $1.91B |
| YoY Revenue Growth % | +9.5% | +24.8% | — |
| Gross Profit | $1.15B | $772.3M | $842.3M |
| Gross Margin % | 44.0% | 32.3% | 44.0% |
| Research & Development (R&D) | — | — | — |
| Operating Income (EBIT) | $527.0M | $502.6M | $373.2M |
| Operating Margin % | 20.1% | 21.0% | 19.5% |
| Net Income (GAAP) | $424.0M | $400.0M | $280.0M |
| EBITDA (Normalized) | $544.9M | $534.3M | $442.2M |
| Diluted EPS ($/sh) | — | — | — |
| Operating Cash Flow (OCF) | $704.1M | $848.6M | $328.5M |
| Capital Expenditures (CapEx) | $22.3M | $39.7M | $86.1M |
| Free Cash Flow (FCF) | $681.8M | $808.9M | $242.3M |
| FCF Margin % | 26.0% | 33.9% | 12.7% |
| Return on Invested Capital (ROIC %) | 21.1% | 20.8% | 9.1% |
| Cash & Short-Term Equivalents | $1.06B | $799.3M | $589.1M |
| Total Debt (Short + Long Term) | $739.3M | $627.8M | $1.25B |
| Total Stockholders' Equity | $2.29B | $2.08B | $2.57B |
NO QUARTERLY 10-Q XBRL STATEMENTS AVAILABLE IN CURRENT CACHE FOR HLI.